FDAapproval84% confidence
Consumer and Health Care Professional Information
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to Merck; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Compounded drugs can serve an important medical need for patients who cannot be treated with an FDA-approved drug, such as a patient who has an allergy and needs a drug to be made without a certain dye, or a child who cannot swallow a tablet or capsule and needs a medicine in a liquid dosage form.
Supporting Context
- Therapeutic area
- Infectious Disease · HIV-1
- Sub-indication
- General
Related signal: Merck Receives FDA Approval for IDVYNSO, Expands Oncology Pipeline and Animal Health Sales